Ongoing Use of Data and Specimens From National Cancer Institute–Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program-Reference-Cited by-同舟云学术

Ongoing Use of Data and Specimens From National Cancer Institute–Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program

Published:2015-10 Issue:5 Volume:42 Page:748-763
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Minasian Lori M.,Tangen Catherine M.,Wickerham D. Lawrence

Funder

Community Clinical Oncology Program (CCOP) Legacy Research Bases

Cancer and Leukemia Group B (CALGB)

North Central Cancer Treatment Group (NCCTG)

Children’s Cancer Group

Pediatric Oncology Group

Eastern Cooperative Oncology Group (ECOG)

National Surgical Adjuvant Breast and Bowel Project (NSABP)

Radiation Therapy Oncology Group

Gynecologic Oncology Group

Southwest Oncology Group (SWOG)

University of Rochester Cancer Center (URCC)

Wake Forest University Cancer Center

SunCoast CCOP Research Base at the University of South Florida

University of Texas MD Anderson Cancer Center

PCPT/SELECT

SELECT- PREADVISE

SELECT-SELECT Eye Endpoints/SEE

SELECT-Respiratory Ancillary Study

SELECT- Colon Polyps Sub Study

STAR – Cognition in STAR/Co-STAR

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference97 articles.

1. Adapting clinical trials networks to promote cancer prevention and control research. Cancer;Weiner;1,2006

2. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med,2003

3. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT);Lippman;JAMA,2009

4. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study;Fisher;J Natl Cancer Inst,2005

5. Effects of tamoxifen v raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial;Vogel;JAMA,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Financial Barriers to the National Cancer Program Implementation in Modern Russia and Means to Overcome Them;The Future of the Global Financial System: Downfall or Harmony;2018-11-04

2. The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials;Cancer Epidemiology;2018-08